Evidence map›Paper›PMID 35360035›Full record

ArticleFrontiers in cardiovascular medicine2022

Atrial Lesions in a Pedigree With

Shaojie Chen, Yongping Lin, Yue Zhu, Le Geng, Chang Cui, Zhaomin Li, Hailei Liu, Hongwu Chen, Weizhu Ju, Minglong Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shaojie ChenDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yongping LinDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yue ZhuDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Le GengDepartment of Cardio-Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chang CuiDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhaomin LiDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hailei LiuDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hongwu ChenDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Weizhu JuDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Minglong ChenDivision of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PRKAG2 cardiomyopathy is a rare progressive disease characterized by increased ventricular wall thickness and preexcitation. Dysfunction of the protein 5'-AMP-activated protein kinase (AMPK) plays a decisive role in the progression of ventricular lesions. Although patients with the

Indexed as

atrial arrhythmiaglycogen depositionhistologypedigreePRKAG2

Identifiers

PMID35360035
PMCPMC8960295
OpenAlexW4220821651

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.